ORGO
Organogenesis Holdings Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables):
amplitud de titulares -6.2% ·
flujo de acciones -2.6% ·
nuevas posiciones netas -13.3%
· fórmula
Distribución amplia: acciones en descenso y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 65 | +3 | 49.96M | $121.38M | +7 | −3 |
| Q1 2026 | 63 | -8 | 40.42M | $96.13M | +5 | −14 |
| Q4 2025 | 72 | +2 | 50.45M | $261.28M | +3 | n/a |
| Q3 2025 | 15 | -1 | 28.00M | $118.17M | n/a | −2 |
| Q2 2025 | 14 | -1 | 16.35M | $59.84M | n/a | −1 |
| Q1 2025 | 12 | +1 | 8.11M | $35.03M | +1 | n/a |
| Q4 2024 | 11 | 0 | 8.24M | $26.36M | n/a | n/a |
| Q3 2024 | 10 | 0 | 7.43M | $21.26M | n/a | n/a |
| Q2 2024 | 10 | n/a | 6.90M | $19.31M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 11.80M | n/a | $49.78M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | The Vanguard Group ✦ (pasivo) | 5.04M | -3.1% | $21.25M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 3 | BlackRock ✦ (pasivo) | 4.58M | -3.1% | $19.35M | 0.0% | ▼ Trim | 2 | SEC ↗ ×7 |
| 4 | Geode Capital Management ✦ (pasivo) | 1.72M | +3.0% | $7.28M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (pasivo) | 1.52M | +0.8% | $6.42M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 821.50K | +2.2% | $3.47M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 706.77K | -1.4% | $2.98M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 8 | D. E. Shaw & Co. ✦ | 511.64K | -16.5% | $2.16M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | JPMorgan Chase ✦ | 428.66K | n/a | $1.81M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 10 | Fidelity (FMR) ✦ | 241.18K | +24.6% | $1.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Goldman Sachs Group ✦ | 229.29K | n/a | $967,587 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Wellington Management ✦ | 229.14K | -45.4% | $966,975 | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 13 | Millennium Management ✦ | 83.23K | -40.1% | $351,222 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 50.59K | -66.4% | $213,507 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 36.45K | +10.8% | $154,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Citadel Advisors | $368,851 | era 0.0% |
| Norges Bank | $237,534 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 121 tenedores, 62.04M acciones, $141.33M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.